Emily M. Jutkiewicz, Ph.D.

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
behavioral pharmacology
Google:
"Emily Jutkiewicz"
Mean distance: 16.18 (cluster 19)
 
SNBCP

Parents

Sign in to add mentor
James H. Woods grad student 2004 University of Michigan
 (Antidepressant effects of the nonpeptidic delta -opioid receptor agonist SNC80.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sanchez GA, Smrcka AV, Jutkiewicz EM. (2024) Biasing Gβγ Downstream Signaling with Gallein Inhibits Development of Morphine Tolerance and Potentiates Morphine-Induced nociception in a Tolerant State. Molecular Pharmacology
Olson KM, Hillhouse TM, Burgess GE, et al. (2022) Delta opioid receptor-mediated antidepressant-like effects of diprenorphine in mice. The Journal of Pharmacology and Experimental Therapeutics
Sanchez G, Jutkiewicz EM, Ingram SL, et al. (2022) Coincident Regulation of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated Antinociception. Molecular Pharmacology
Rysztak LG, Jutkiewicz EM. (2022) The role of enkephalinergic systems in substance use disorders. Frontiers in Systems Neuroscience. 16: 932546
Robertson SH, Rice KC, Jutkiewicz EM. (2022) The Effects of Activation and Blockade of Delta Opioid Receptors on the Acquisition of Responding for an Opioid-Associated Stimulus. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology
Burgess GE, Sanghvi S, Thomas J, et al. (2022) Mu opioid receptor (MOR) agonist-induced antihyperalgesic effects following spared nerve injury in male and female rats. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology
Hillhouse TM, Olson K, Hallahan JE, et al. (2021) The Journal of Pharmacology and Experimental Therapeutics
Johnson CR, Kangas BD, Jutkiewicz EM, et al. (2021) Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition. The Journal of Pharmacology and Experimental Therapeutics
Altshuler RD, Mac RC, Gnegy ME, et al. (2020) PKC inhibition decreases amphetamine-maintained responding under a progressive-ratio schedule of reinforcement. Experimental and Clinical Psychopharmacology
Dripps IJ, Chen R, Shafer AM, et al. (2020) Pharmacological Properties of Delta Opioid Receptor-Mediated Behaviors: Agonist Efficacy and Receptor Reserve. The Journal of Pharmacology and Experimental Therapeutics
See more...